ENDRA Life Sciences Inc logo

ENDRA Life Sciences Inc (NDRA)

Market Closed
29 Jan, 20:00
NASDAQ (CM) NASDAQ (CM)
$
5. 25
+0.25
+5%
$
2.58M Market Cap
- P/E Ratio
0% Div Yield
4,200 Volume
-1.41 Eps
$ 5
Previous Close
Day Range
5.02 5.32
Year Range
4.01 2,240
Earnings results expected in 55 days

Summary

NDRA closed today higher at $5.25, an increase of 5% from yesterday's close, completing a monthly decrease of -16.13% or $1.01. Over the past 12 months, NDRA stock lost -16.13%.
NDRA is not paying dividends to its shareholders.
The last earnings report, released on Nov 12, 2024, missed the consensus estimates by -7.76%. On average, the company has fell short of earnings expectations by -2.73%, based on the last three reports. The next scheduled earnings report is due on Mar 26, 2025.
ENDRA Life Sciences Inc has completed 3 stock splits, with the recent split occurring on Nov 07, 2024.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).
Want to track NDRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

NDRA Chart

FAQ

What Is the ENDRA Life Sciences Inc(NDRA) Stock Price Today?

The NDRA stock price today is $5.25.

What Stock Exchange Does ENDRA Life Sciences Inc Trade On?

ENDRA Life Sciences Inc is listed and trades on the NASDAQ (CM).

What Is the Stock Symbol for ENDRA Life Sciences Inc?

The stock symbol for ENDRA Life Sciences Inc is "NDRA".

Does ENDRA Life Sciences Inc Pay Dividends? What's The Current Dividend Yield?

NDRA is not paying dividends to its shareholders.

What Is the ENDRA Life Sciences Inc Market Cap?

As of today, ENDRA Life Sciences Inc market cap is 2.58M.

What is ENDRA Life Sciences Inc Earnings Per Share?

The ENDRA Life Sciences Inc EPS is 0.

What Is the Next ENDRA Life Sciences Inc Earnings Date?

ENDRA Life Sciences Inc will release its next earnings report on Mar 26, 2025.

Did ENDRA Life Sciences Inc had any splits?

ENDRA Life Sciences Inc had 3 splits and the recent split was on Nov 07, 2024.

ENDRA Life Sciences Inc Profile

Diagnostics & Research Industry
Healthcare Sector
Mr. Francois Michelon CEO
NASDAQ (CM) Exchange
US29273B1044 ISIN
US Country
21 Employees
- Last Dividend
9 Dec 2022 Last Split
9 May 2017 IPO Date

Overview

ENDRA Life Sciences Inc. is a pioneering company focused on enhancing the capabilities of clinical diagnostic ultrasound through advanced technology. Based in Ann Arbor, Michigan, and incorporated in 2007, ENDRA Life Sciences strives to revolutionize the way diseases are diagnosed and treated, with a special focus on nonalcoholic fatty liver disease. The company has made significant strides in the field through its collaboration with General Electric Company, showcasing its commitment to integrating cutting-edge research and development into practical medical applications.

Products and Services

ENDRA Life Sciences Inc. offers a range of innovative diagnostic imaging technologies aimed at improving patient care through more accurate and non-invasive diagnostics. These technologies include:

  • Thermo-Acoustic Enhanced Ultrasound Technology: This flagship technology utilizes sound waves that interact with body tissues, organs, and blood. The interaction generates images that can assist in the diagnosis and treatment of various conditions, including nonalcoholic fatty liver disease. This technology stands out for its ability to provide more detailed images compared to traditional ultrasound, offering significant advancements in understanding tissue composition, measuring temperature changes, conducting vascular imaging, and assessing tissue perfusion.
  • Computed Tomography (CT): ENDRA Life Sciences harnesses the power of CT scans to create detailed images of the inside of the body. CT scans are particularly useful in diagnosing cancers, investigating signs of heart disease, and detecting internal bleeding or broken bones. The technology offers a non-invasive way to guide treatment plans and understand the internal workings of the human body in greater detail.
  • Magnetic Resonance Imaging (MRI): MRI is another critical tool in ENDRA’s arsenal, providing detailed images of the body’s organs and tissues using magnetic fields and radio waves. This technology is invaluable for diagnosing a wide range of conditions, from brain and spinal cord injuries to tumors and diseases affecting the joints. Its non-invasive nature and the detailed images it produces make MRI an essential tool in modern medicine.
  • Ultrasound: Beyond its enhanced ultrasound technology, ENDRA also offers traditional ultrasound imaging, a versatile diagnostic method used to capture live images of the internal structures of the body. It is widely used in various medical scenarios, such as monitoring the health of fetuses during pregnancy, diagnosing gallbladder disease, and evaluating other conditions that require visualization of soft tissue structures.

Contact Information

Address: 3600 Green Court, Ann Arbor, MI, United States, 48105-1570
Phone: 734 335 0468